The Potential of Single Nucleotide Polymorphisms (SNPs) as Biomarkers and Their Association with the Increased Risk of Coronary Heart Disease: A Systematic Review

References

• Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014;114(12):1852–1866. doi:10.1161/CIRCRESAHA.114.302721
   PubMed Web of Science ®Google Scholar
• Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111(25):3481–3488. doi:10.1161/CIRCULATIONAHA.105.537878
   PubMed Web of Science ®Google Scholar
• Baihaqi WM, Setiawan NA, Ardiyanto I. Rule extraction for fuzzy expert system to diagnose Coronary artery disease. Proceedings - 2016 1st International Conference on Information Technology, Information Systems and Electrical Engineering; ICITISEE; 2016:136–141.
   Google Scholar
• Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021. doi:10.1016/j.jacc.2020.11.010
   PubMed Web of Science ®Google Scholar
• Sayols-Baixeras S, Lluís-Ganella C, Lucas G, Elosua R. Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants. Appl Clin Genet. 2014;7(7):15. doi:10.2147/TACG.S35301
   PubMedGoogle Scholar
• Orho-Melander M. Genetics of coronary heart disease: towards causal mechanisms, novel drug targets and more personalized prevention. J Intern Med. 2015;278(5):433–446. doi:10.1111/joim.12407
   PubMed Web of Science ®Google Scholar
• Kessler T, Erdmann J, Schunkert H. Genetics of coronary artery disease and myocardial infarction - 2013. Curr Cardiol Rep. 2013;15(6):1–8. doi:10.1007/s11886-013-0368-0
   Web of Science ®Google Scholar
• Khera AV, Emdin CA, Drake I, et al. Genetic risk, adherence to a healthy lifestyle, and coronary disease. N Engl J Med. 2016;375(24):2349–2358. doi:10.1056/NEJMoa1605086
   PubMed Web of Science ®Google Scholar
• Zeng L, Talukdar HA, Koplev S, et al. Contribution of regulatory-gene networks to heritability of coronary artery disease. J Am Coll Cardiol. 2019;73(23):2946. doi:10.1016/j.jacc.2019.03.520
   PubMed Web of Science ®Google Scholar
• Nikpay M, Goel A, Won HH, et al. A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet. 2015;47(10):1121.
   PubMed Web of Science ®Google Scholar
• Morieri ML, Gao H, Pigeyre M, et al. Genetic tools for coronary risk assessment in type 2 diabetes: a cohort study from the ACCORD clinical trial. Diabetes Care. 2018;41(11):2404–2413. doi:10.2337/dc18-0709
   PubMed Web of Science ®Google Scholar
• Sumi MP, Mahajan B, Sattar RSA, et al. Elucidation of epigenetic landscape in coronary artery disease: a review on basic concept to personalized medicine. Epigenet Insights. 2021:14. doi:10.1177/2516865720988567
   Web of Science ®Google Scholar
• Dent THS. Predicting the risk of coronary heart disease. II: the role of novel molecular biomarkers and genetics in estimating risk, and the future of risk prediction. Atherosclerosis. 2010;213(2):352–362. doi:10.1016/j.atherosclerosis.2010.06.021
   PubMed Web of Science ®Google Scholar
• Qamar T, Mukherjee S. Genetic approaches for the diagnosis and treatment of rheumatoid arthritis through personalized medicine. Gene Rep. 2021;23(1):1–9.
   Google Scholar
• Hindi NN, Alenbawi J, Nemer G. Pharmacogenomics variability of lipid-lowering therapies in familial hypercholesterolemia. J Pers Med. 2021;11(9):877. doi:10.3390/jpm11090877
   PubMed Web of Science ®Google Scholar
• Xu LB, Zhang YQ, Zhang NN, et al. Rs10757274 gene polymorphisms in coronary artery disease. Medicine. 2020;99(3). doi:10.1097/MD.0000000000018841
   Web of Science ®Google Scholar
• Li X, Lin Y, Zhang R. Associations between endothelial nitric oxide synthase gene polymorphisms and the risk of coronary artery disease: a systematic review and meta-analysis of 132 case-control studies. Eur J Prev Cardiol. 2019;26(2):160–170. doi:10.1177/2047487318780748
   PubMed Web of Science ®Google Scholar
• Salari N, Mansouri K, Hosseinian-Far A, et al. The effect of polymorphisms (174G> C and 572C> G) on the Interleukin-6 gene in coronary artery disease: a systematic review and meta-analysis. Genes Environ. 2021;43(1). doi:10.1186/s41021-021-00172-8
   PubMed Web of Science ®Google Scholar
• Tabaei S, Motallebnezhad M, Tabaee SS. Systematic review and meta-analysis of association of polymorphisms in inflammatory cytokine genes with coronary artery disease. Inflamm Res. 2020;69(10):1001–1013. doi:10.1007/s00011-020-01385-3
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;2021:372.
   Google Scholar
• Aromataris E, Munn Z. JBI Manual for Evidence Synthesis; 2020; Available from: https://wiki.jbi.global/display/MANUAL/11.1+Introduction+to+Scoping+reviews. Accessed May 2, 2023.
   Google Scholar
• Conway R, Grimshaw AA, Konig MF, et al. SARS–CoV-2 infection and COVID-19 outcomes in rheumatic diseases: a systematic literature review and meta-analysis. Arthritis Rheumatol. 2022;74(5):766–775. doi:10.1002/art.42030
   PubMed Web of Science ®Google Scholar
• Davies NM, Holmes MV, Smith Davey G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:1.
   Google Scholar
• Goplen CM, Verbeek W, Kang SH, et al. Preoperative opioid use is associated with worse patient outcomes after Total joint arthroplasty: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2019;20(1). doi:10.1186/s12891-019-2619-8
   Google Scholar
• Tada H, Fujino N, Nomura A, et al. Personalized medicine for cardiovascular diseases. J Hum Genet. 2021;66(1):67–74. doi:10.1038/s10038-020-0818-7
   PubMed Web of Science ®Google Scholar
• Hu P, Dharmayat KI, Stevens CAT, et al. Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis. Circulation. 2020;141(22):1742–1759. doi:10.1161/CIRCULATIONAHA.119.044795
   PubMed Web of Science ®Google Scholar
• Dandona S, Stewart AFR, Chen L, et al. Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. J Am Coll Cardiol. 2010;56(6):479–486. doi:10.1016/j.jacc.2009.10.092
   PubMed Web of Science ®Google Scholar
• Nordlie MA, Wold LE, Kloner RA. Genetic contributors toward increased risk for ischemic heart disease. J Mol Cell Cardiol. 2005;39:4. doi:10.1016/j.yjmcc.2005.06.006
   Web of Science ®Google Scholar
• Tomkin H. GLDL as a cause of atherosclerosis. Open Atheroscler Thromb J. 2012;5(1):13–21.
   Google Scholar
• Saleheen D, Haycock PC, Zhao W, et al. Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a Mendelian randomisation analysis. Lancet Diabetes Endocrinol. 2017;5(7):524–533. doi:10.1016/S2213-8587(17)30088-8
   PubMed Web of Science ®Google Scholar
• Wang JY, Zhang YJ, Li H, et al. CRISPLD1 rs12115090 polymorphisms alters antiplatelet potency of clopidogrel in coronary artery disease patients in Chinese Han. Gene. 2018;678:226–232. doi:10.1016/j.gene.2018.08.027
   PubMed Web of Science ®Google Scholar
• Alliey-Rodriguez N, Grey TA, Shafee R, et al. NRXN1 is associated with enlargement of the temporal horns of the lateral ventricles in psychosis. Transl Psychiatry. 2019;9(1):1–7. doi:10.1038/s41398-019-0564-9
   PubMedGoogle Scholar
• Park HS, Kim IJ, Kim EG, et al. A study of associations between CUBN, HNF1A, and LIPC gene polymorphisms and coronary artery disease. Sci Rep. 2020;10(1):1–10. doi:10.1038/s41598-019-56847-4
   PubMed Web of Science ®Google Scholar
• Teupser D, Burkhardt R, Wilfert W, Haffner I, Nebendahl K, Thiery J. Identification of macrophage arginase I as a new candidate gene of atherosclerosis resistance. Arterioscler Thromb Vasc Biol. 2006;26:2. doi:10.1161/01.ATV.0000195791.83380.4c
   Web of Science ®Google Scholar
• Meroufel D, Dumont J, Médiène-Benchekor S, et al. Characterization of arginase 1 gene polymorphisms in the Algerian population and association with blood pressure. Clin Biochem. 2009;42(10–11):1178–1182. doi:10.1016/j.clinbiochem.2009.03.004
   PubMed Web of Science ®Google Scholar
• Shah SFA, Khan MJ, Iqbal T, et al. Arginase-1 variants and the risk of familial coronary artery disease in subjects originating from Pakistan. Genet Test Mol Biomarkers. 2019;23(1):32–38. doi:10.1089/gtmb.2018.0227
   PubMed Web of Science ®Google Scholar
• Yang Z, Ming XF, Conway R, Grimshaw AA, Konig MF. Functions of arginase isoforms in macrophage inflammatory responses: impact on cardiovascular diseases and metabolic disorders. Front Immunol. 2014;5. doi:10.3389/fimmu.2014.00533
   Web of Science ®Google Scholar
• Pernow J, Jung C. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? Cardiovasc Res. 2013;98(3):334–343. doi:10.1093/cvr/cvt036
   PubMed Web of Science ®Google Scholar
• Vinayagamoorthy N, Hu HJ, Yim SH, et al. New variants including ARG1 polymorphisms associated with C-reactive protein levels identified by genome-wide association and pathway analysis. PLoS One. 2014;9(4):e95866. doi:10.1371/journal.pone.0095866
   PubMed Web of Science ®Google Scholar
• Jakubowski H. Pathophysiological consequences of homocysteine excess. J Nutr. 2006;136(6):1741S–1749S. doi:10.1093/jn/136.6.1741S
   PubMed Web of Science ®Google Scholar
• Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ. 2002;325(7374):1202. doi:10.1136/bmj.325.7374.1202
   PubMed Web of Science ®Google Scholar
• Masud R, Baqai HZ. The communal relation of MTHFR, MTR, ACE gene polymorphisms and hyperhomocysteinemia as conceivable risk of coronary artery disease. Appl Physiol Nutr Metab. 2017;42(10):1009–1014. doi:10.1139/apnm-2017-0030
   PubMed Web of Science ®Google Scholar
• Alie N, Eldib M, Fayad ZA, Mani V. Inflammation, atherosclerosis, and coronary artery disease: PET/CT for the evaluation of atherosclerosis and inflammation. Clin Med Insights Cardiol. 2015;8(Suppl 3):13–21. doi:10.4137/CMC.S17063
   PubMedGoogle Scholar
• Auer J, Weber T, Berent R, Lassnig E, Lamm G, Eber B. Genetic polymorphisms in cytokine and adhesion molecule genes in coronary artery disease. Am J Pharmacogenomics. 2003;3(5):317–328. doi:10.2165/00129785-200303050-00003
   PubMedGoogle Scholar
• Duarte VHR, Miranda CT, De OF, et al. TREML4 mRNA expression and polymorphisms in blood leukocytes are associated with atherosclerotic lesion extension in coronary artery disease. Sci Rep. 2019;9(1). doi:10.1038/s41598-019-43745-y
   Google Scholar
• Sen SK, Boelte KC, Barb JJ, et al. Integrative DNA, RNA, and protein evidence connects TREML4 to coronary artery calcification. Am J Hum Genet. 2014;95(1):66–76. doi:10.1016/j.ajhg.2014.06.003
   PubMed Web of Science ®Google Scholar
• Ansari WM, Humphries SE, Naveed AK, Khan OJ, Khan DA. Influence of cytokine gene polymorphisms on proinflammatory/anti-inflammatory cytokine imbalance in premature coronary artery disease. Postgrad Med J. 2017;93(1098):209–214. doi:10.1136/postgradmedj-2016-134167
   PubMed Web of Science ®Google Scholar
• Mitrokhin V, Nikitin A, Brovkina O, et al. Association between IL-18/18R gene polymorphisms and coronary artery disease: influence of IL-18/18R genetic variants on cytokine expression. J Inflamm Res. 2018;11:1–9. doi:10.2147/JIR.S153370
   PubMed Web of Science ®Google Scholar
• Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol. 2001;112(1–2):146–152. doi:10.1016/S0165-5728(00)00407-0
   PubMed Web of Science ®Google Scholar
• Chen H, Ding S, Liu X, Wu Y, Wu X. Association of interleukin-6 genetic polymorphisms and environment factors interactions with coronary artery disease in a Chinese han population. Clin Exp Hypertens. 2018;40(6):514–517. doi:10.1080/1064196320171403618
   PubMed Web of Science ®Google Scholar
• Klimushina MV, Gumanova NG, Kutsenko VA, et al. Association of common polymorphisms in IL-6 and IL6ST genes with levels of inflammatory markers and coronary stenosis. Meta Gene. 2019;21:100593. doi:10.1016/j.mgene.2019.100593
   Web of Science ®Google Scholar
• Zorzetto M, Ferrarotti I, Trisolini R, et al. Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003;168(3):330–334. doi:10.1164/rccm.200302-221OC
   PubMed Web of Science ®Google Scholar
• de Vries MA, Trompet S, Mooijaart SP, et al. Complement receptor 1 gene polymorphisms are associated with cardiovascular risk. Atherosclerosis. 2017;257:16. doi:10.1016/j.atherosclerosis.2016.12.017
   PubMed Web of Science ®Google Scholar
• Koch W, Kastrati A, Böttiger C, Mehilli J, Von Beckerath N, Schömig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis. 2001;159(1):137–144. doi:10.1016/S0021-9150(01)00467-1
   PubMed Web of Science ®Google Scholar
• Ghalandari M, Jamialahmadi K, Nik MM, et al. Association of Interleukin-10-592 C > A gene polymorphism with coronary artery disease: a case-control study and meta-analysis. Cytokine. 2021;139:5.
   Web of Science ®Google Scholar
• Smolková B, Bonassi S, Buociková V, et al. Genetic determinants of quantitative traits associated with cardiovascular disease risk. Mutat Res. 2015;778:18–25. doi:10.1016/j.mrfmmm.2015.05.005
   PubMed Web of Science ®Google Scholar
• Orsatti CL, Sobreira ML, Sandrim VC, Nahas-Neto J, Orsatti FL, Nahas EAP. Autophagy-related 16-like 1gene polymorphism, risk factors for cardiovascular disease and associated carotid intima-media thickness in postmenopausal women. Clin Biochem. 2018;61:12–17. doi:10.1016/j.clinbiochem.2018.09.006
   PubMed Web of Science ®Google Scholar
• Lange RA, Hillis LD. Antiplatelet therapy for ischemic heart disease. N Engl J Med. 2004;350(3):277–280. doi:10.1056/NEJMe038191
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhu J, Li H, et al. Study of the association of PEAR1, P2Y12, and UGT2A1 polymorphisms with platelet reactivity in response to dual antiplatelet therapy in Chinese patients. Cardiology. 2018;140(1):21–29. doi:10.1159/000488101
   PubMed Web of Science ®Google Scholar
• Faraday N, Yanek LR, Yang XP, et al. Identification of a specific intronic PEAR1 gene variant associated with greater platelet aggregability and protein expression. Blood. 2011;118(12):3367–3375. doi:10.1182/blood-2010-11-320788
   PubMed Web of Science ®Google Scholar
• Enrique Herrera-Galeano J, Becker DM, Wilson AF, et al. A novel variant in the platelet endothelial aggregation receptor-1 gene is associated with increased platelet aggregability. Arterioscler Thromb Vasc Biol. 2008;28(8):1484–1490. doi:10.1161/ATVBAHA.108.168971
   PubMed Web of Science ®Google Scholar
• Su J, Yu Q, Yang J, et al. The association of polymorphisms in related circadian rhythm genes and clopidogrel resistance susceptibility. Basic Clin Pharmacol Toxicol. 2021;129(3):196–209. doi:10.1111/bcpt.13622
   PubMed Web of Science ®Google Scholar
• Schroder EA, Lefta M, Zhang X, et al. The cardiomyocyte molecular clock, regulation of Scn5a, and arrhythmia susceptibility. Am J Physiol Cell Physiol. 2013;304:10. doi:10.1152/ajpcell.00383.2012
   Web of Science ®Google Scholar
• Alibhai FJ, LaMarre J, Reitz CJ, et al. Disrupting the key circadian regulator CLOCK leads to age-dependent cardiovascular disease. J Mol Cell Cardiol. 2017;105:24–37. doi:10.1016/j.yjmcc.2017.01.008
   PubMed Web of Science ®Google Scholar
• Schlaepfer IR, Clegg HV, Corley RP, et al. The human protein kinase C gamma gene (PRKCG) as a susceptibility locus for behavioral disinhibition. Addict Biol. 2007;12(2):200–209. doi:10.1111/j.1369-1600.2007.00063.x
   PubMed Web of Science ®Google Scholar
• Zafar MU, Paz-Yepes M, Shimbo D, et al. Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression. Eur Heart J. 2010;31(13):1573–1582. doi:10.1093/eurheartj/ehp602
   PubMed Web of Science ®Google Scholar
• Drago A, Monti B, de Ronchi D, Serretti A. CRY1 variations impacts on the depressive relapse rate in a sample of bipolar patients. Psychiatry Investig. 2015;12(1):118. doi:10.4306/pi.2015.12.1.118
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang Y, Zhang Q, et al. The effects of CACNA1C gene polymorphism on prefrontal cortex in both schizophrenia patients and healthy controls. Schizophr Res. 2019;204:193–200. doi:10.1016/j.schres.2018.09.007
   PubMed Web of Science ®Google Scholar
• Laing E, Hess P, Shen Y, Wang J, Hu S. The role and impact of SNPs in pharmacogenomics and personalized medicine. Curr Drug Metab. 2011;12(5):460–486. doi:10.2174/138920011795495268
   PubMed Web of Science ®Google Scholar
• Vrablik M, Dlouha D, Todorovova V, Stefler D, Hubacek JA. Genetics of cardiovascular disease: how far are we from personalized CVD risk prediction and management? Int J Mol Sci. 2021;22:4182. doi:10.3390/ijms22084182
   PubMed Web of Science ®Google Scholar
• Ho DSW, Schierding W, Wake M, Saffery R, O’Sullivan J. Machine learning SNP based prediction for precision medicine. Front Genet. 2019;10:267. doi:10.3389/fgene.2019.00267
   PubMed Web of Science ®Google Scholar
• Bachtiar M, Ooi BNS, Wang J, et al. Towards precision medicine: interrogating the human genome to identify drug pathways associated with potentially functional, population-differentiated polymorphisms. Pharmacogenomics J. 2019;19(6):516–527. doi:10.1038/s41397-019-0096-y
   PubMed Web of Science ®Google Scholar
• Pott J, Schlegel V, Teren A, et al. Genetic regulation of PCSK9 (proprotein convertase subtilisin/kexin type 9) plasma levels and its impact on atherosclerotic vascular disease phenotypes. Circ Genom Precis Med. 2018;11(5). doi:10.1161/CIRCGEN.117.001992
   PubMed Web of Science ®Google Scholar